Resumen

AGUILAR, Alicia et al. In vitro neutralization assay to evaluate new hepatitis A vaccine candidates. Vaccimonitor [online]. 2010, vol.19, n.1, pp.16-19. ISSN 1025-028X.

Immunity to hepatitis A virus (HAV) is in first instance due to neutralizing antibodies. Neutralization assays are essential to evaluate new candidate vaccines against this pathogen. In this paper, an in vitro neutralization assay to evaluate HAV vaccine candidates using phage-display technology is described. 10³ and 10² DICT₅₀ of HAV were incubated with different antibodies preparations and were inoculated onto plates with FRhK4 cells. After seven days of incubation, the neutralizing titer was determined as reciprocal of the serum dilution reducing HAV growth (inhibition of CPE) by 50%. 10³ and 10² DICT50 were neutralized by 7E7 anti-HAV monoclonal antibody and anti-VHA positive human sera (A12 and A31). Negative controls of the assay did not neutralize viral infectivity. Sera from mice immunized with phages displaying VHA mimotopes had neutralizing titers from 4-16. Neither negative control nor pre-immune and sera from mice immunized with M13 wild type phage neutralized HAV. A simple and faster in vitro neutralization assay was developed to evaluate new HAV vaccine candidates.

Palabras clave : HAV; neutralization; mimotope; immunogenicity; phages.

        · resumen en Español     · texto en Español     · Español ( pdf )